
Moderna Inc. has also noted, though not published data, that its new mRNA-1273.351 vaccine was able to boost the immune response of previously vaccinated animals to provide increased activity against the B.1.351 variant.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3amL2iF
via
IFTTT
0 comments:
Post a Comment